ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -20.0% | 206 | 0.0% | 0.01% | +200.0% |
| Q1 2022 | $15,000 | -16.7% | 206 | -1.0% | 0.00% | -25.0% |
| Q4 2021 | $18,000 | -5.3% | 208 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $19,000 | -5.0% | 206 | -1.0% | 0.00% | -20.0% |
| Q2 2021 | $20,000 | -16.7% | 208 | -3.3% | 0.01% | -16.7% |
| Q1 2021 | $24,000 | -68.0% | 215 | -60.2% | 0.01% | -57.1% |
| Q4 2020 | $75,000 | +70.5% | 540 | -0.2% | 0.01% | +55.6% |
| Q3 2020 | $44,000 | +7.3% | 541 | +2.5% | 0.01% | 0.0% |
| Q2 2020 | $41,000 | +78.3% | 528 | +3.9% | 0.01% | +50.0% |
| Q1 2020 | $23,000 | +64.3% | 508 | +52.1% | 0.01% | +100.0% |
| Q4 2019 | $14,000 | +600.0% | 334 | +882.4% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 34 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $3,000 | +50.0% | 34 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 34 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 34 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 34 | -97.7% | 0.00% | – |
| Q4 2017 | $2,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |